SIDEfxHUB

Charity Number: 1203385
Charity reporting is up to date (on time)

Charity overview

Activities - how the charity spends its money

The charity provides funds for research to increase understanding or the cause and treatment of Post Finasteride Syndrome and other Iatrogenic diseases for the benefit of sufferers without geographical limit

Income and expenditure

Data for financial year ending 01 August 2024

Total income: £30,902
Total expenditure: £27,261

People

5 Trustee(s)

Employees with total benefits over £60,000

No information available

Fundraising

No information available

Trading

This charity does not have any trading subsidiaries.

Trustee payments

No trustees receive any remuneration, payments or benefits from the charity.

What, who, how, where

Main way of carrying out purposes is grant making
What the charity does:
  • The Advancement Of Health Or Saving Of Lives
Who the charity helps:
  • Other Charities Or Voluntary Bodies
  • The General Public/mankind
How the charity helps:
  • Provides Other Finance
Where the charity operates:
  • Throughout England And Wales

Governance

Registration history:
  • 05 June 2023: CIO registration
Organisation type:
CIO
Other names:
  • PFS Organisation (Previous name)
  • PFS UK (Previous name)
Gift aid:
Not recognised by HMRC for gift aid
Other regulators:
No information available
Policies:
  • Complaints handling
  • Complaints policy and procedures
  • Safeguarding policy and procedures
  • Safeguarding vulnerable beneficiaries
  • Serious incident reporting policy and procedures
  • Social media policy and procedures
Land and property:
This charity does not own and/or lease land or property

Trustees

Trustees are the people responsible for controlling the work, management and administration of the charity on behalf of its beneficiaries. Generally trustees are treasurer, chair, board member etc. The trustees are responsible for keeping this list up to date and can do this by updating their details as they happen through the online service

5 Trustee(s)

Name Role Date of appointment Other trusteeships Reporting status of other trusteeships
Gary Shields Chair 05 June 2023
None on record
Ryan Clark Trustee 17 February 2025
None on record
Bernard Morlet Trustee 04 February 2025
None on record
Robert Dixon Trustee 04 February 2025
None on record
Katharine Hayden Trustee 05 June 2023
None on record

Financial history

" role="img"> Text alternative for this canvas graphic is in the data table below.

Financial period end date

Income / Expenditure 01/08/2024
Total gross income £30.90k
Total expenditure £27.26k
Income from government contracts N/A
Income from government grants N/A

Accounts and annual returns

This table shows the charity's record of submitting annual returns, accounts and trustees' annual report (TAR) for the last five financial periods.
Title Reporting year Date received Received Download
Annual return 01 August 2024 23 May 2025 On Time
Accounts and TAR 01 August 2024 23 May 2025 On Time Download Open in new window
Submit annual return Open in new window

Governing document

Details of the type of governing document the charity has and when it was established.
It is not the full text of the charity's governing document.

CIO - FOUNDATION Registered 05 Jun 2023 as amended on 04 Mar 2024

Charitable objects

TO PROMOTE SCIENTIFIC RESEARCH INTO THE PREVENTION, CURE, MANAGEMENT AND ALLEVIATION OF IATROGENIC DISEASE, INCLUDING BUT NOT LIMITED TO POST FINASTERIDE SYNDROME, BY PROVIDING FUNDING ON CONDITION THAT THE USEFUL RESULTS OF SUCH RESEARCH MUST BE DISSEMINATED FOR THE PUBLIC BENEFIT. IATROGENIC DISEASE MEANS A CONDITION DUE TO EXPOSURE TO PATHOGENS, TOXINS OR INJURIOUS TREATMENT OR PROCEDURES. POST FINASTERIDE SYNDROME REFERS TO THE PHYSICAL, NEUROLOGICAL AND SEXUAL SYMPTOMS THAT MAY OCCUR IN PERSONS AFTER THEY STOP TAKING FINASTERIDE OR OTHER 5-ALPHA REDUCTASE INHIBITORS.

Contact information

Address:
66 LEAM TERRACE
LEAMINGTON SPA
66 LEAM TERRACE
LEAMINGTON SPA
CV
Phone:
07808777651
Email:
contact@sidefxhub.com
Website:

www.sidefxhub.com Open in new window